Skip to main content

Table 1 Patient characteristics

From: Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors

 All (n = 62)DR (n = 11)True PD (n = 51)P
nn%n%
Agemedian 65, range 27–82      
≥75112189181.000
< 7551     
GenderMale4076433651.000
Female22     
Performance status0,14687338751.000
2–416     
Smoking statusCurrent/former4565539760.155
Never17     
HistologySquamous cell carcinoma1221810201.000
Non-squamous cell carcinoma50     
Adenocarcinoma (n = 46), Others (n = 4)      
Driver mutationPositive1532712240.696
EGFR L858R/19del (n = 12), ALK (n = 3)      
Negative47     
Line of treatment2nd line3276425490.511
3rd line or beyond30     
PD-L1 status<  1800816 
1 ≤287642141 
Unknown264402243 
TreatmentNivolumab459203680 
Pembrolizumab7229571 
Atezolizumab100010100 
  1. Abbreviations: DR dissociated responses, PD-L1 programmed cell death-ligand 1, True PD true progressive disease